<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04049721</url>
  </required_header>
  <id_info>
    <org_study_id>s19-01074</org_study_id>
    <nct_id>NCT04049721</nct_id>
  </id_info>
  <brief_title>Use of Hyperbaric Oxygen Therapy for the Treatment of Crush Injuries</brief_title>
  <official_title>Use of Hyperbaric Oxygen Therapy for the Treatment of Crush Injuries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Winthrop University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether using hyperbaric oxygen (HBO) improves
      wound healing for patients who have a crush injury. The comparison of the prospective
      intervention group to the retrospective matched cohort aims to show that HBO can improve
      wound healing and decrease poor outcomes for patients with crush injuries. The information
      gained from this small study will serve as a basis for a follow-up prospective, randomized
      control trial to further delineate the role of HBO in a larger patient population.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2019</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>healing measured by percentage of skin necrosis using a Bilateral Perfusion Index (BPI; TCOM of the affected limb/TCOM of the nonaffected limb).</measure>
    <time_frame>week 2</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>healing measured by percentage of skin necrosis using a Bilateral Perfusion Index (BPI; TCOM of the affected limb/TCOM of the nonaffected limb).</measure>
    <time_frame>week 6</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>healing measured by percentage of skin necrosis using a Bilateral Perfusion Index (BPI; TCOM of the affected limb/TCOM of the nonaffected limb).</measure>
    <time_frame>week 24</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>healing measured by percentage of skin necrosis using a Bilateral Perfusion Index (BPI; TCOM of the affected limb/TCOM of the nonaffected limb).</measure>
    <time_frame>week 52</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>hospital length of stay</measure>
    <time_frame>52 Weeks</time_frame>
    <description>Number of days admitted over 52 weeks</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Crush Injury</condition>
  <arm_group>
    <arm_group_label>Standard of Care without HBO</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous access and fluid resuscitation (standard of care treatment)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HBO + Standard of Care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ten daily treatment sessions of HBO at 2.5 atmospheres absolute (ATA) with 90 minutes of hyperbaric oxygen will be given over the course of two weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>HBO</intervention_name>
    <description>2.5 atmospheres absolute (ATA) with 90 minutes of hyperbaric oxygen will be given over the course of two weeks.</description>
    <arm_group_label>HBO + Standard of Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of Care</intervention_name>
    <description>20 patients will be included in the retrospective review arm. The retrospective chart review will be performed to determine the outcomes of patients with crush injuries treated at NYU Winthrop Hospital without HBO from 1/1/2012-12/31/2018.</description>
    <arm_group_label>HBO + Standard of Care</arm_group_label>
    <arm_group_label>Standard of Care without HBO</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presenting to NYU Winthrop Hospital with a crush injury of the extremity, including
             appendages, up to 14 days post injury.

          -  No contraindication to hyperbaric oxygen therapy.

          -  Able and willing to sign informed consent.

        Exclusion Criteria:

          -  Critically-ill patient requiring intubation or pressor support.

          -  Crush injury isolated to the distal phalanx (Tuft fracture).

          -  Absolute contraindication to hyperbaric oxygen therapy (untreated pneumothorax).
             Relative contraindications (uncontrolled congestive heart failure, uncontrolled
             seizure disorder, pulmonary disease, claustrophobia) will be assessed by the treating
             physician.

          -  Unable or unwilling to sign informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrizio Petrone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York Langone Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrizio Petrone, MD</last_name>
    <phone>516-663-9571</phone>
    <email>Patrizio.Petrone@nyulangone.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>NYU Langone Health</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Patrizio Petrone, MD</last_name>
      <phone>516-663-9571</phone>
      <email>Patrizio.Petrone@nyulangone.org</email>
    </contact>
    <investigator>
      <last_name>Patrizio Petrone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 30, 2019</study_first_submitted>
  <study_first_submitted_qc>August 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 8, 2019</study_first_posted>
  <last_update_submitted>August 7, 2019</last_update_submitted>
  <last_update_submitted_qc>August 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crush Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research</ipd_time_frame>
    <ipd_access_criteria>The investigator who proposed to use the data.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

